DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Costa OS, Beyer-Westendorf J, Ashton V. et al.
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data.
Curr Med Res Opin 2020;
36 (07) 1081-1088
We do not assume any responsibility for the contents of the web pages of other providers.